HealthGene Editing Tool CRISPR Used To Correct Blood Clotting, Treat Hemophilia In Mice The CRISPR gene editing system was used by a pioneering research aiming to treat hemophilia B. In order to eliminate the rare genetic condition, the researchers used mice in their experiments.by Livia Rusu
Healthy Living/WellnessBetting Big on Gene Therapy: Pfizer Partners with Spark Therapeutics for Hemophilia Treatmentby Rhodi Lee
Healthy Living/WellnessFDA approves hemophilia B drug Alprolix for children and adultsby Lori Sandoval
Healthy Living/WellnessHemophilia B drug Alprolix given the go-ahead in Canada, with U.S. approval imminentby Tabitha Laffernis